Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study

Background The present study aimed to clarify the beneficial effect of allopurinol on cardiovascular morbidity and mortality in a cohort of hypertensive nephropathy patients with impaired kidney function. Methods One hundred and seventy-eight patients diagnosed with hypertensive nephropathy and pres...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental nephrology 2013-08, Vol.17 (4), p.549-553
Main Authors: Terawaki, Hiroyuki, Nakayama, Masaaki, Miyazawa, Emiko, Murata, Yaeko, Nakayama, Keisuke, Matsushima, Masato, Miyazaki, Mariko, Sato, Hiroshi, Sato, Mitsuhiro, Sato, Toshinobu, Taguma, Yoshio, Ito, Sadayoshi
Format: Article
Language:English
Subjects:
Aged
Allopurinol - therapeutic use
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - mortality
Cardiovascular Diseases - prevention & control
Disease-Free Survival
Female
Humans
Hypertension, Renal - complications
Hypertension, Renal - drug therapy
Incidence
Japan - epidemiology
Male
Medicine
Medicine & Public Health
Middle Aged
Nephritis - complications
Nephritis - drug therapy
Nephrology
Original Article
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The present study aimed to clarify the beneficial effect of allopurinol on cardiovascular morbidity and mortality in a cohort of hypertensive nephropathy patients with impaired kidney function. Methods One hundred and seventy-eight patients diagnosed with hypertensive nephropathy and presenting with impaired kidney function (estimated glomerular filtration rate
ISSN:1342-1751
1437-7799
DOI:10.1007/s10157-012-0742-z